Oncology
Oncology
-
Name: Pazopanib
CAS :444731-52-6
Registration/Standard :
Details -
Name: Axitinib
CAS :319460-85-0
Registration/Standard :
Details -
Name: Abiraterone acetate
CAS :154229-18-2
Registration/Standard :
Details -
Name: Enzalutamide
CAS :915087-33-1
Registration/Standard :
Details -
Name: Olaparib
CAS :763113-22-0
Registration/Standard :
Details -
Name: Lenalidomide
CAS :191732-72-6
Registration/Standard :
Details -
Name: Sorafenib
CAS :284461-73-0
Registration/Standard :
Details -
Name: Niraparib tosylate
CAS :1613220-15-7
Registration/Standard :
Details -
Name: Lorlatinib (PF0643922)
CAS :1454846-35-5
Registration/Standard :
Details -
Name: Capmatinib
CAS :1029712-80-8
Registration/Standard :
Details -
Name: Crizotinib
CAS :877399-52-5
Registration/Standard :
Details -
Name: Cabozantinib S-malate
CAS :1140909-48-3
Registration/Standard :
Details -
Name: Ensartinib
CAS :1365267-27-1
Registration/Standard :
Details -
Name: Repotrectinib
CAS :1802220-02-5
Registration/Standard :
Details -
Name: Larotrectinib sulfate
CAS :1223405-08-0
Registration/Standard :
Details -
Name: Selitrectinib
CAS :2097002-61-2
Registration/Standard :
Details -
Name: Tucatinib
CAS :937263-43-9
Registration/Standard :
Details -
Name: Erlotinib hydrochloride
CAS :183322-18-1
Registration/Standard :
Details -
Name: Vandetanib
CAS :443913-73-3
Registration/Standard :
Details -
Name: Vismodegib
CAS :879085-55-9
Registration/Standard :
Details
line
Copyright(C)2020,Hangzhou Jinlan Pharm-Drugs Technology Co., Ltd. All Rights Reserved.